# Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With Obesity

> **NCT06809166** · PHASE4 · RECRUITING · sponsor: **The Royal's Institute of Mental Health Research** · enrollment: 40 (estimated)

## Conditions studied

- Obesity
- Weight Loss
- Weight Management
- Dietary Intervention
- Obesity/Therapy

## Interventions

- **DRUG:** Contrave
- **DRUG:** Placebo
- **BEHAVIORAL:** Diet Program

## Key facts

- **NCT ID:** NCT06809166
- **Lead sponsor:** The Royal's Institute of Mental Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-04
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-07-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-07-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06809166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06809166, "Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With Obesity". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT06809166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*